Can we reduce cardiovascular deaths by preventing a recurrence of atrial fibrillation? Dr. Eric Prystowsky, Director of Electrophysiology at St. Vincent Hospital in Indianapolis, Indiana, will discuss the results of the ATHENA trial; a study using dronedarone, an amiodarone-like medication, that was shown to significantly reduce cardiovascular deaths and hospitalizations due to atrial fibrillation and acute coronary syndromes. Join host Dr. Matthew Sorrentino.
Facebook Comments